ViroPharma Incorporated

(NASDAQ:VPHM)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Assets
Current Assets
Cash & Equivalents 612,808 496,534 324,211 179,691
Restricted Cash
Marketable Securities 55,557 136,342 274,794 404,637
Accounts Receivable 22,918 27,225 22,690 17,684
Loans Receivable
Other Receivable 675 1,963 3,374 5,937
Receivables 23,593 29,188 26,064 23,621
Raw Materials 3,088 3,624 3,355
Work in Progress
Purchased Components
Finished Goods 2,053 1,548 1,348
Other Inventories 4,675
Inventories Adjustments and Allowances
Inventories 5,141 4,675 5,172 4,703
Prepaid Expenses 1,096 5,109 6,493 2,138
Current Deferred Income Taxes 1,008 2,892 7,277 7,983
Other Current Assets
Total Current Assets 699,203 674,740 644,011 622,773
Land and Improvements 380
Building and Improvements 9,410
Machinery Furniture and Equipment 3,576
Construction in Progress
Other Fixed Assets 16,919 14,325 14,154
Total Fixed Assets 16,919 14,325 14,154 13,366
Gross Fixed Assets 16,919 14,325 14,154 13,366
Accumulated Depreciation and Depletion 2,476 2,476 2,476 2,476
Net Fixed Assets 14,443 11,849 11,678 10,890
Intangibles 124,197 125,668 122,891 122,502
Cost in Excess
Non Current Deferred Income Taxes 7,243 6,133 8,146 12,312
Other Non Current Assets 9,438 7,608 7,386 7,589
Total Non Current Assets 155,321 151,258 150,101 153,293
Total Assets 854,524 825,998 794,112 776,066
Liabilities
Current Liabilities
Accounts Payable 4,497 1,809 2,038 2,017
Notes Payable
Short Term Debt
Accrued Expenses 21,493 27,493 21,447 18,687
Accrued Liabilities
Deferred Revenues
Current Deferred Income Tax Liabilities
Other Current Liabilities 1,441 1,441 1,066 7,666
Total Current Liabilities 27,431 30,743 24,551 28,370
Non Current Liabilities
Long Term Debt 250,000 250,000 250,000 250,000
Capital Lease Obligations
Deferred Income Tax Liabilities
Other Non Current Liabilities 2,919 2,171 2,131 1,133
Minority Interest Liabilities
Preferred Securities of Subsidiary Trust Liabilities
Preferred Equity Outside Stock Equity
Total Non Current Liabilities 280,350 282,914 276,682 279,503
Total Liabilities 252,919 252,171 252,131 251,133
Shareholders' Equity
Preferred Stock Equity
Common Stock Equity 574,174 543,084 517,430 496,563
Common Par 140 140 140 140
Additional Paid in Capital 506,402 502,654 500,549 498,350
Cumulative Translation Adjustment
Retained Earnings 67,213 40,139 16,069 -1,381
Treasury Stock
Other Equity Adjustments 419 151 672 -546
Total Capitalization 824,174 793,084 767,430 746,563
Cash Flow 96,625 90,864 98,099 102,277
Working Capital 671,772 643,997 619,460 594,403
Free Cash Flow 88,504 49,705 13,332 108,051
Invested Capital 824,174 793,084 767,430 746,563
Total Equity 574,174 543,084 517,430 496,563
Total Liabilities and Stock Equity 854,524 825,998 794,112 776,066